Best diagnosis & testing programme

This award recognises the impact of diagnosis and testing programmes in helping to improve identification of hepatitis C in the UK.

Submissions may include initiatives around increasing screening uptake; developing new pathways to improve access to diagnostics leading to increased identification; developing innovative models and diagnostic services that demonstrate improved access to diagnosis and testing. 

Entries should demonstrate evidence of the following:

  • Clearly defined project scope
  • Engagement, analysis and understanding of the local community
  • Patient centricity - improved patient care and outcomes
  • Assessment of quality improvement before and after the change initiative
  • Impact on staff and/or the organisation
  • Change through innovation
  • Teamwork
  • Transferability to other areas/organisations/departments and sectors
  • Linkage back to care


Judging criteria:

ObjectivesAre the objectives clearly explained and appropriate to the initiative?0-5 points
Planning & implementationHow effective were the methods used to deliver the initiative? How well were they implemented? 0-10 points
Impact & resultsHow successful was the initiative? How well did it meet its objectives? 0-10 points
Patient experienceHow was patient experience measured and how well was the initiative received by patients?0-20 points
Audit & evaluation Was the initiative subject to formal evaluation and were the measures of success appropriate? What evidence-based data exists to support the success of the programme?0-20 points
Future benefitsWhat impact does the project potentially have in the future?0-10 points
SustainabilityHow sustainable was the initiative? What level of impact has the project had (relative to available budget/resources) within its intended environment?0-10 points
ReplicationHow easily could the initiative be adapted to other health authorities?0-10 points
InnovationTo what extent was the initiative innovative or pioneering?0-5 points

  • KEY DATES FOR 2017 TO BE ANNOUNCED
QiC Hepatitis C is supported by: